Skip to content

Comparing Two Devices of Uterine Manipulation and Vaginal Fornix Delineation at Total Laparoscopic Hysterectomy

Comparing Two Devices of Uterine Manipulation and Vaginal Fornix Delineation at Total Laparoscopic Hysterectomy

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02197728
Enrollment
91
Registered
2014-07-23
Start date
2014-02-28
Completion date
2015-12-31
Last updated
2019-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Laparoscopic Hysterectomy for Benign Conditions

Keywords

hysterectomy, uterine manipulator, thermal damage, laparoscopy, colpotomy

Brief summary

We hypothesize, that the use of the Hohl manipulator® at total laparoscopic hysterectomy reduces operative time (from skin incision to detachment of the uterus) and lateral termal damage of the vaginal wall during colpotomy due to the following reasons: (1) Uterine manipulation is better with the Hohl manipulator®, thereby facilitating dissection during all aspects of the surgery, (2) more tension can be applied on the vagina during colpotomy, thereby hastening electrosurgical transection, reducing activation time and reduce lateral thermal damage and (3) tension on the vagina can be applied until the colpotomy is finished, due to the tight connection between the Hohl manipulator® and the cervix of the uterus, which also affects speed of transection, electrosurgical device activation time and lateral thermal damage.

Interventions

DEVICEUse of the Colpo-Probe™ Vaginal Fornix Delineator or Hohl manipulator® during total laparoscopic hysterectomy

Sponsors

Unity Health Toronto
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* All women aged over 18 years, scheduled for a laparoscopic hysterectomy for a benign disorder will be asked to participate and included after written informed consent.

Exclusion criteria

* pregnancy * malignancy * if uterine size exceeds 20 weeks of gestation * or if the uterus could be removed by a vaginal approach

Design outcomes

Primary

MeasureTime frameDescription
Detachment of the uterus45 minutes to 3 hoursOperative time from skin incision to detachment of uterus. Times are routinely collected by operating room nursing staff.
Thermal Damage2 weeks post surgeryLateral thermal damage to the vagina will be measured on the specimen (in mm) at the time of pathologic evaluation.
Colpotomy3 minutes to 20 minutesTime from first monopolar energy activation to completion of colpotomy. Operative times are routinely collected by operating room nursing staff.

Secondary

MeasureTime frameDescription
Blood Loss45 minutes to 3 hoursTotal amount of blood lost throughout surgery. Measured in cc.
Pain24h post surgeryAmount of post operative pain measured using a pain sensitivity scale.
Manipulator Installmentintraoperative

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026